Release Date: 16/02/09 16:36 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 13.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%